200 filings
Page 2 of 10
8-K
nen221
7 Dec 23
Other Events
4:09pm
8-K
2kkde
29 Nov 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / November 2023
6:37am
SC TO-I/A
y32a8mo 5usdc10be66z
28 Nov 23
Issuer tender offer statement (amended)
4:01pm
CORRESP
le9rtgcq nc9l
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
ds0s6rpv3gzeo8ede
21 Nov 23
Letter from SEC
12:00am
8-K
q6f9r
14 Nov 23
BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
SC TO-I
wirkez3gf9 ni
9 Nov 23
Issuer tender offer statement
5:23pm
8-K
grsyn16 7z76i
31 Oct 23
Departure of Directors or Certain Officers
5:05pm
8-K
5oybz fn7vqpieb
18 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
b8od32 m7j
29 Aug 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
dwyk8newjvl 6xmfcet
9 Aug 23
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
6:48am
8-K
ky5n9ky8
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:16pm
25-NSE
ts2w8zk56cwwg3
12 Jun 23
Exchange delisting
10:48am
424B3
3305q7ql2h41tgw3s
9 Jun 23
Prospectus supplement
4:01pm
EFFECT
r5i13kn7a
9 Jun 23
Notice of effectiveness
12:15am